Published in:
Open Access
01-07-2012 | Poster presentation
IL-10 is a critical negative regulator of macrophage activation syndrome
Authors:
Scott Canna, Katharine Slade, Michele Paessler, Portia Kreiger, Sheila Rao, Edward M Behrens
Published in:
Pediatric Rheumatology
|
Special Issue 1/2012
Login to get access
Excerpt
Macrophage Activation Syndrome (MAS, alternatively known as secondary Hemophagocytic Lymphohistiocytosis (HLH)) is a potentially life-threatening complication of many rheumatologic, infectious, and malignant diseases. It is characterized by the acute onset of disseminated intravascular coagulopathy and multi-system organ dysfunction in the setting of overwhelming inflammation. As a result of the poor understanding of disease pathogenesis, no consensus exists regarding how best to diagnose and treat this condition. Preliminary evidence in genetic forms of this disease (known collectively as primary HLH) suggests a critical role for IFNγ and CD8+ T-lymphocytes. …
